7 тысяч подписчиков
737 видео
Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers
Treatment Innovation in DLBCL: Real-World Insight on Integrating Antibodies and Cellular Therapy
See Drs. Javle, Borad, He, & Rocha discuss
Innovation in CLL The Practicalities and Potential of Finite Therapy With BTKi Platforms
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer
Ten Steps for Highly Successful Myeloma Care
Watch Drs. Salem & Yarchoan discuss
The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals
Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options
Modern Team-Based Therapeutic Management for Bladder Cancer Care
Decoding Biomarker Testing and Targeted Therapy in NSCLC
Taking the Leap With Innovative Strategies in MCL
Unleashing the Innovation Era in AML
Maximizing the Role of ADCs in Urothelial Carcinoma
Advancing Immunotherapy in Cervical Cancer Care
Optimizing Prophylactic Management of Hemophilia With Novel and Emerging Non-Factor Therapies
Innovative Immunotherapy in Advanced Basal Cell Carcinoma
Drs. Liu, Lim, & Rodriguez discuss
Innovations in AML: New Developments With Menin Inhibitors in Challenging Subtypes
Selective, Potent, Different: Next-Generation ROS1 and TRK Inhibition in NSCLC and Other Tumors
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC
#BreastCancer
Embracing the Era of Individualized Therapy in Advanced Biliary Cancers
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
Watch Drs. Donington & Spicer discuss
Three Rs for Modern Myeloma Care
Watch Drs. Shore, Kamat & Meeks discuss
Mapping a New Treatment Journey in NF1
Precision Care for Myelodysplastic Syndromes
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
Transforming MCL Management Guidance on Selecting and Using BTKi Platforms as First Line Therapy
Enhanced Outcomes in Pediatric ALL and Modern Asparaginase Therapy
